AlphAIalphai — Financial news for AI agents
SEC EDGARJUL 152 min read$VRSK

Mann Elizabeth sold $77K of VRSK

Mann Elizabeth (Chief Financial Officer) sold 400 shares of Verisk Analytics, Inc. (VRSK) at $192.11 on 2026-07-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Mann Elizabeth
Published Jul 15, 2026, 8:19 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 15, 2026, 8:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$VRSK
Neutral
high confidence
Mentioned
$VRSK
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VRSKNeutralLow
01

Why it matters

Because it is a planned open-market sale and not a buy or a non-routine event, it provides little new information about Verisk’s near-term performance.

02

Market read

Traders may note the disclosure for sentiment monitoring, but it is unlikely to drive a fundamental repricing.

03

What to watch

The transaction size ($76.8k) is small relative to typical large-cap trading flows, and 10b5-1 plans are designed to reduce timing-based inference.

Relevance 2/10Novelty 2/10Timing: Filed 2026-07-15, after-hours SEC Form 4 disclosure

Background

The article is a primary-source SEC Form 4 insider transaction by Verisk’s CFO, Elizabeth Mann, marked as a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$VRSKNeutralHigh confidence
Context

Verisk CFO Elizabeth Mann filed a Form 4 selling 400 shares at $192.11 on 2026-07-15 under a 10b5-1 plan.

Expected impact

Likely negligible immediate price impact; any effect is more about optics than new company information.

Evidence & confidence

The filing is an open-market sale by an officer, explicitly noted as pre-arranged under Rule 10b5-1, and contains no new operational, financial, or regulatory facts.

Market effects

Sector

No sector read-through; insider sale does not change Verisk’s business outlook.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Even with 10b5-1, some traders may interpret insider selling as mild caution, especially if clustered with other recent sales.

Key entities

  • issuer
    Verisk Analytics, Inc.

    Company whose CFO insider sale is disclosed on SEC Form 4.

  • insider
    Elizabeth Mann

    Chief Financial Officer who sold 400 shares under a 10b5-1 plan.

Read at source← All news

Related articles

AUG 8
$VRSKMedAI 8/10

Verisk Analytics (VRSK) Q2 2026 Earnings Call Transcript

Verisk Analytics (NASDAQ:VRSK) reported Q2 2026 revenue of $806 million, up 4.3% reported and 5.8% organic constant currency. Adjusted EBITDA was $464 million, up 7.4% on the same basis. Subscription revenue was 83% of total, and diluted adjusted EPS was $1.98. Full-year guidance was reaffirmed: revenue $3.19B to $3.24B and EPS $7.45 to $7.75.

aol.com6 min
AUG 7
$VRSKMedAI 8/10

Verisk Ordered to Move Ahead With $2.35 Billion AccuLynx Merger

A Delaware Chancery Court judge ordered Verisk Analytics to proceed with its $2.35 billion merger with AccuLynx, rejecting AccuLynx’s bid to raise the deal price over antitrust clearance concerns. The judge cited willful conduct by AccuLynx for a failed closing condition and awarded AccuLynx damages for direct costs plus interest. The deal still requires HSR Act clearance and FTC approval.

news.bloomberglaw.com4 min
JUL 29
$VRSKMedAI 8/10

[VRSK Q2 2026 Earnings Call] Verisk Q2 Organic Revenue Hits 5.8% as XactAI Users Jump 10x to 7,000, but Transactional Drag Persists — BigGo Finance

Verisk Analytics (VRSK) reported Q2 2026 revenue of $806 million, up 5.8% organic constant currency, driven by 8% subscription growth (83% of revenue). Transactional revenue fell 4.2% due to softer commercial property quotes and weaker weather demand. XactAI users rose 10x to 7,000. Full-year guidance of $3.19–$3.24B revenue and $1.79–$1.83B adj. EBITDA was reaffirmed.

finance.biggo.com7 min
JUL 29
$VRSKMed

Verisk Vaults on Releasing Q2 Results

Verisk (NASDAQ: VRSK) reported Q2 results for the quarter ended June 30, 2026. Net income fell 9.8% to $229 million, citing higher tax rate, net interest expense, and legal fees tied to litigation. The company paid a $0.50 dividend per share and launched a $200 million accelerated share repurchase, with an initial delivery of 949,190 shares at $179.10. Shares rose 9.6% to $221.87.

baystreet.ca3 min